Atara Bio hikes IPO target from $50 million to $92 million By: San Francisco Business Times via Business Journals July 10, 2014 at 20:41 PM EDT Atara Biotherapeutics Inc. supersized its planned IPO to up to $92 million, offering 5.75 million shares at a range of $14 to $16 each... Read More >> Related Stocks: Alexandria Real Estate Equities
